Safety Study of HBI-8000 in Japanese Patients With Non Hodgkin's Lymphoma

NCT02697552 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
13
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

HUYABIO International, LLC.